尿液可溶性CD163与活检证实的ANCA相关肾小球肾炎疾病活动度的关系
该研究在95例ANCA相关血管炎患者中分析尿液可溶性CD163与肾活检组织学特征的关系,共125份肾组织切片(首次活检67份、重复活检58份)配合同期24小时尿样。结果显示尿液可溶性CD163与活动性ANCA相关肾小球肾炎相关,与纤维素样坏死和细胞性新月体相关,对识别复发性ANCA相关肾小球肾炎的敏感度为0.94、特异度为0.91。
要点
- 尿液可溶性CD163在87%的活动性ANCA相关肾小球肾炎活检中升高。
- 尿液可溶性CD163与纤维素样坏死(Rho=0.48)和细胞性新月体(Rho=0.70)相关。
- 重复活检中识别复发性ANCA相关肾小球肾炎的敏感度0.94、特异度0.91。
核心结论
- 尿液可溶性CD163与活动性ANCA相关肾小球肾炎相关,并与肾活检组织学特征相关。
研究设计与样本
- 研究分析了95例接受肾活检的ANCA相关血管炎患者的尿液可溶性CD163。
- 共研究125份肾组织切片(首次肾活检n=67;重复活检n=58)配合同期24小时尿样。
- 采用Spearman秩相关分析尿液可溶性CD163水平与ANCA相关肾小球肾炎形态学特征的相关性。
- 采用受试者工作特征曲线分析评估生物标志物检测复发性ANCA相关肾小球肾炎的诊断性能。
主要发现
- 110份活动性ANCA相关肾小球肾炎活检中96份(87%)尿液可溶性CD163水平高,而无活动性ANCA相关肾小球肾炎的15份活检中仅1份(7%)水平高。
- 17例健康对照中仅1例(6%)尿液可溶性CD163水平高。
- 尿液可溶性CD163与肾活检纤维素样坏死相关(Rho=0.48,P<0.001)。
- 尿液可溶性CD163与肾活检细胞性新月体相关(Rho=0.70,P<0.001)。
- 重复活检中,尿液可溶性CD163识别复发性ANCA相关肾小球肾炎的敏感度为0.94、特异度为0.91,表现优于常规临床指标。
关键数值与推荐
- 活动性ANCA相关肾小球肾炎活检中尿液可溶性CD163升高比例为87%(96/110)。
- 无活动性ANCA相关肾小球肾炎活检中尿液可溶性CD163升高比例为7%(1/15)。
- 健康对照中尿液可溶性CD163升高比例为6%(1/17)。
- 尿液可溶性CD163与纤维素样坏死相关:Rho=0.48,P<0.001。
- 尿液可溶性CD163与细胞性新月体相关:Rho=0.70,P<0.001。
临床怎么用
- 尿液可溶性CD163可作为活动性ANCA相关肾小球肾炎的无创标志物,辅助识别疾病活动。
- 在重复活检场景中,尿液可溶性CD163对识别复发性ANCA相关肾小球肾炎具有较高敏感度和特异度。
- 尿液可溶性CD163水平与肾活检纤维素样坏死和细胞性新月体相关,可提示组织学活动度。
局限性
- 既往研究缺乏组织学数据,本研究通过肾活检组织学分析弥补了这一局限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: ANCA-associated GN is a common cause of rapidly progressive GN, with high relapse rates. The early recognition of an ANCA-associated GN relapse is of importance to prevent loss of kidney function. Urinary soluble CD163 has been identified as a promising marker of active ANCA-associated GN. Previous studies, however, are limited by the lack of histologic data. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We analyzed urinary soluble CD163 in 95 patients with ANCA-associated vasculitis who underwent a kidney biopsy. In total, 125 kidney tissue sections (first kidney biopsy, n=67; repeated biopsy, n=58) with concurrent 24-hour urine samples were studied. Correlation analyses comparing urinary soluble CD163 levels and morphologic features of ANCA-associated GN were performed using Spearman rank correlation analysis. The diagnostic performance of biomarkers to detect relapsing ANCA-associated GN was evaluated using receiver operating characteristics curve analysis. RESULTS: High levels of urinary soluble CD163 were found in 96 (87%) of 110 biopsies with active ANCA-associated GN compared with one (7%) of 15 biopsies without active ANCA-associated GN and one (6%) of 17 healthy controls. Urinary soluble CD163 correlated with fibrinoid necrosis (Rho=0.48, P<0.001) and cellular crescents (Rho=0.70, P<0.001) on kidney biopsy. In repeated biopsies, urinary soluble CD163's sensitivity of 0.94 and specificity of 0.91 for the recognition of relapsing ANCA-associated GN appeared better than routine clinical measures. The presence of CD163+ cells in affected glomeruli confirmed urinary soluble CD163's origin. CONCLUSIONS: Urinary soluble CD163 is associated with active ANCA-associated GN and correlates with histologic features as seen in ANCA-associated GN. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2020_11_17_CJN07210520_final.mp3.
引用
- Aendekerk JP, Timmermans SAMEG, Busch MH, et al. Urinary Soluble CD163 and Disease Activity in Biopsy-Proven ANCA-Associated Glomerulonephritis. Clin J Am Soc Nephrol. 2020. PMID: 33203735. doi:10.2215/CJN.07210520
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。